A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2017
At a glance
- Drugs Polyphenon E (Primary)
- Indications Bladder cancer
- Focus Pharmacodynamics
- 17 Oct 2017 Status changed to completed.
- 31 Jul 2015 New trial record
- 19 May 2015 Results presented at the 110th Annual Meeting of the American Urological Association.